Terminated NA INTERVENTIONAL 4-arm NCT04971096

Relationship Between Gut Microbiome, Probiotics, and Mild Cognitive Impairment

Sponsor: Bened Biomedical Co., Ltd.

Conditions Mild Cognitive Impairment (MCI)

Interventions PS23 heat-treated PS23 live Placebo

Updated 7 times since 2021 Last updated: Aug 5, 2025 Started: Apr 1, 2022 Primary completion: Jan 16, 2024 Completion: Jan 16, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Difficult to include the patient.

Other terminated trials from Bened Biomedical Co., Ltd.

More terminations from Bened Biomedical Co., Ltd.

Other Mild Cognitive Impairment (MCI) trials with similar outcome

Browse all Mild Cognitive Impairment (MCI) trials

This NA trial investigates Mild Cognitive Impairment (MCI) and is currently terminated or withdrawn. Bened Biomedical Co., Ltd. leads this study, which shows 7 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated NA

Status: Unknown → Terminated
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Aug 2024 — Sep 2024 [monthly]

Unknown NA

Status: Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 2 earlier versions

May 2022 — Sep 2022 [monthly]

Not Yet Recruiting NA
Sep 2021 — May 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bened Biomedical Co., Ltd.
Mackay Memorial Hospital

Data source: Mackay Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taipei, Taiwan